Inventor · disambiguated record
Liliane Unger
Also filed as: HAGER-WERNET ANDREA · HAGER-WERNET LEGAL REPRESENTATIVE ANDREA · HORNBERGER WILFRIED · UNGER LILIANE
125 granted patents·26 pending applications·928 citations·filing 1986–2018
99Inventor score
Top patents by PatentIndex Score
151 records- 0194US7119097B2Carboxylic acid derivatives, their preparation and their useABBOTT GMBH & CO KG·Filed 2006·Granted Oct 10, 2006·13 cites·18 claims
- 0294US7109205B2Carboxylic acid derivatives, their preparation and useABBOTT GMBH & CO KG·Filed 2003·Granted Sep 19, 2006·31 cites·18 claims
- 0393US8350055B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2010·Granted Jan 8, 2013·23 cites·8 claims
- 0491US8129389B2Substituted oxindole derivatives, medicaments containing the latter and use thereofLUBISCH WILFRIED·Filed 2006·Granted Mar 6, 2012·19 cites·10 claims
- 0590US8703774B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesNETZ ASTRID·Filed 2008·Granted Apr 22, 2014·11 cites·17 claims
- 0690US8076326B2N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted Dec 13, 2011·23 cites·28 claims
- 0790US7902379B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2004·Granted Mar 8, 2011·27 cites·4 claims
- 0889US8546401B25,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseasesBRAJE WILFRIED·Filed 2008·Granted Oct 1, 2013·11 cites·25 claims
- 0989US7601730B2Carboxylic acid derivatives, their preparation and useABBOTT GMBH & CO KG·Filed 2006·Granted Oct 13, 2009·7 cites·16 claims
- 1089US6600043B2Carboxylic acid derivatives, their preparation and useBASF AG·Filed 2000·Granted Jul 29, 2003·17 cites·20 claims
- 1188US8815868B2Substituted oxindole derivatives and their use as vasopressin receptor ligandsNETZ ASTRID·Filed 2007·Granted Aug 26, 2014·8 cites·55 claims
- 1288US8440694B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2012·Granted May 14, 2013·12 cites·13 claims
- 1387US8859557B2Substituted oxindole derivatives and their use as vasopressin receptor ligandsNETZ ASTRID·Filed 2012·Granted Oct 14, 2014·7 cites·22 claims
- 1487US8703775B2Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnessesOOST THORSTEN·Filed 2008·Granted Apr 22, 2014·10 cites·14 claims
- 1587US5932730ACarboxylic acid derivatives, their preparation and useBASF AG·Filed 1995·Granted Aug 3, 1999·41 cites·11 claims
- 1685US5703091AN-substituted azabicycloalkane derivatives, their preparation and useBASF AG·Filed 1994·Granted Dec 30, 1997·59 cites·3 claims
- 1783US8183237B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted May 22, 2012·4 cites·17 claims
- 1883US7951807B2Substituted oxindol derivatives and medicaments containing the sameABBOTT GMBH & CO KG·Filed 2005·Granted May 31, 2011·5 cites·7 claims
- 1983US6579892B1Triazole compounds with dopamine-D3-receptor affinityABBOTT LAB·Filed 2000·Granted Jun 17, 2003·20 cites·9 claims
- 2082US5958923AUse of thiazole and thiadiazole compoundsBASF AG·Filed 1995·Granted Sep 28, 1999·31 cites·11 claims
- 2180US8343959B2N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2011·Granted Jan 1, 2013·5 cites·10 claims
- 2280US7790727B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2008·Granted Sep 7, 2010·4 cites·31 claims
- 2380US6602867B1Triazole compounds with dopamine-D3-receptor affinityABBOTT LAB·Filed 2000·Granted Aug 5, 2003·15 cites·18 claims
- 2480US6352981B1Substituted AZA- and diazacycloheptane and -cyclooctaneBASF AG·Filed 2000·Granted Mar 5, 2002·14 cites·15 claims
- 2579US7803834B2Substituted oxindole derivatives, drugs containing said derivatives and the use thereofABBOTT GMBH & CO KG·Filed 2006·Granted Sep 28, 2010·3 cites·24 claims
- 2679US6090807AUse of heterocyclic compoundsBASF AG·Filed 1995·Granted Jul 18, 2000·59 cites·10 claims
- 2777US8629148B2Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnessesBRAJE WILFRIED·Filed 2008·Granted Jan 14, 2014·2 cites·32 claims
- 2876US7851463B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Dec 14, 2010·2 cites·21 claims
- 2976US7320979B2N-[(piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2004·Granted Jan 22, 2008·7 cites·22 claims
- 3076US6472392B1Triazole compounds and the use thereof as dopamine-D3 -ligandsABBOTT LAB·Filed 1999·Granted Oct 29, 2002·46 cites·14 claims
- 3176US5969134ACarboxylic acid derivatives, their preparation and useBASF AG·Filed 1998·Granted Oct 19, 1999·19 cites·9 claims
- 3275US8710059B2N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2011·Granted Apr 29, 2014·3 cites·20 claims
- 3375US6197958B1Carboxylic acid derivatives, their preparation and useBASF AG·Filed 1999·Granted Mar 6, 2001·18 cites·10 claims
- 3474US9023854B25-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseasesBRAJE WILFRIED·Filed 2008·Granted May 5, 2015·1 cites·34 claims
- 3574US8242102B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Aug 14, 2012·2 cites·23 claims
- 3674US8044079B2Substituted oxindole derivatives, medicaments containing said derivatives and use thereofABBOTT GMBH & CO KG·Filed 2006·Granted Oct 25, 2011·1 cites·17 claims
- 3773US9422264B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 23, 2016·1 cites·21 claims
- 3873US8969552B2Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Mar 3, 2015·2 cites·25 claims
- 3973US8580842B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themLUBISCH WILFRIED·Filed 2010·Granted Nov 12, 2013·2 cites·5 claims
- 4073US7863445B2Carboxylic acid derivatives, their preparation and useABBOTT GMBH & CO KG·Filed 2009·Granted Jan 4, 2011·0 cites·18 claims
- 4173US6583166B1Triazole compounds with dopamine-D3-receptor affinityABBOTT LAB·Filed 2000·Granted Jun 24, 2003·7 cites·20 claims
- 4272US8772313B2Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2011·Granted Jul 8, 2014·2 cites·21 claims
- 4372US8362010B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2010·Granted Jan 29, 2013·2 cites·23 claims
- 4471US8232426B2Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorDRESCHER KARLA·Filed 2005·Granted Jul 31, 2012·1 cites·19 claims
- 4571US8202870B2Substituted oxindole derivatives, medicaments containing the latter and use thereofLUBISCH WILFRIED·Filed 2006·Granted Jun 19, 2012·1 cites·5 claims
- 4670US9487505B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 8, 2016·1 cites·8 claims
- 4769US4914125A(S)-emopamil for the treatment of migraineKNOLL AG·Filed 1989·Granted Apr 3, 1990·14 cites·1 claims
- 4868US9388148B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·1 cites·6 claims
- 4968US8507469B2Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorSCHULTZ THOMAS·Filed 2008·Granted Aug 13, 2013·2 cites·44 claims
- 5068US8431567B2Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligandsGENESTE HERVE·Filed 2007·Granted Apr 30, 2013·1 cites·22 claims
Showing the top 50 of 151 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Liliane Unger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →